Literature DB >> 25818430

Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.

Zhipeng Chen1, Liujie Zhang2, Yang Song3, Jiayu He4, Li Wu4, Can Zhao4, Yanyu Xiao5, Wei Li4, Baochang Cai4, Haibo Cheng4, Weidong Li6.   

Abstract

The overwhelming majority of drugs exert their pharmacological effects after reaching their target sites of action, however, these target sites are mainly located in the cytosol or intracellular organelles. Consequently, delivering drugs to the specific organelle is the key to achieve maximum therapeutic effects and minimum side-effects. In the work reported here, we designed, synthesized, and evaluated a novel mitochondrial-targeted multifunctional nanoparticles (MNPs) based on chitosan derivatives according to the physiological environment of the tumor and the requirement of mitochondrial targeting drug delivery. The intelligent chitosan nanoparticles possess various functions such as stealth, hepatocyte targeting, multistage pH-response, lysosomal escape and mitochondrial targeting, which lead to targeted drug release after the progressively shedding of functional groups, thus realize the efficient intracellular delivery and mitochondrial localization, inhibit the growth of tumor, elevate the antitumor efficacy, and reduce the toxicity of anticancer drugs. It provides a safe and efficient nanocarrier platform for mitochondria targeting anticancer drug delivery.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Drug delivery; Hierarchical; Mitochondrial-targeted; Multifunctional nanoparticles; pH-response

Mesh:

Substances:

Year:  2015        PMID: 25818430     DOI: 10.1016/j.biomaterials.2015.02.001

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  9 in total

Review 1.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

2.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

3.  Design, characterization, and intracellular trafficking of biofunctionalized chitosan nanomicelles.

Authors:  Weiyi Li; Giulia Suarato; Jillian M Cathcart; Paul R Sargunas; Yizhi Meng
Journal:  Biointerphases       Date:  2020-11-13       Impact factor: 2.456

Review 4.  Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.

Authors:  Shringika Soni; Rakesh Kumar Ruhela; Bikash Medhi
Journal:  Adv Pharm Bull       Date:  2016-09-25

Review 5.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

6.  Preparation of endostatin-loaded chitosan nanoparticles and evaluation of the antitumor effect of such nanoparticles on the Lewis lung cancer model.

Authors:  Rui-Lin Ding; Fang Xie; Yue Hu; Shao-Zhi Fu; Jing-Bo Wu; Juan Fan; Wen-Feng He; Yu He; Ling-Lin Yang; Sheng Lin; Qing-Lian Wen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery.

Authors:  Rui Chen; Liu Xu; Qin Fan; Man Li; Jingjing Wang; Li Wu; Weidong Li; Jinao Duan; Zhipeng Chen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 8.  Stimuli-responsive chitosan-based nanocarriers for cancer therapy.

Authors:  Marziyeh Fathi; Parham Sahandi Zangabad; Sima Majidi; Jaleh Barar; Hamid Erfan-Niya; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-11-15

9.  Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy.

Authors:  Yang Chen; Cejun Yang; Juan Mao; Haigang Li; Jinsong Ding; Wenhu Zhou
Journal:  RSC Adv       Date:  2019-04-09       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.